Redefining Cirrhotic Cardiomyopathy for the Modern Era

on behalf of The Cirrhotic Cardiomyopathy Consortium

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Cirrhotic cardiomyopathy (CCM) is cardiac dysfunction in patients with end-stage liver disease in the absence of prior heart disease. First defined in 2005 during the World Congress of Gastroenterology, CCM criteria consisted of echocardiographic parameters to identify subclinical cardiac dysfunction in the absence of overt structural abnormalities. Significant advancements in cardiovascular imaging over the past 14 years, including the integration of myocardial deformation imaging into routine clinical practice to identify subclinical cardiovascular dysfunction, have rendered the 2005 CCM criteria obsolete. Therefore, new criteria based on contemporary cardiovascular imaging parameters are needed. In this guidance document, assembled by a group of multidisciplinary experts in the field, new core criteria based on contemporary cardiovascular imaging parameters are proposed for the assessment of CCM. This document provides a critical assessment of the diagnosis of CCM and ongoing assessment aimed at improving clinical outcomes, particularly surrounding liver transplantation. Key points and practice-based recommendations for the diagnosis of CCM are provided to offer guidance for clinicians and identify gaps in knowledge for future investigations.

Original languageEnglish (US)
Pages (from-to)334-345
Number of pages12
JournalHepatology
Volume71
Issue number1
DOIs
StatePublished - Jan 1 2020

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'Redefining Cirrhotic Cardiomyopathy for the Modern Era'. Together they form a unique fingerprint.

  • Cite this

    on behalf of The Cirrhotic Cardiomyopathy Consortium (2020). Redefining Cirrhotic Cardiomyopathy for the Modern Era. Hepatology, 71(1), 334-345. https://doi.org/10.1002/hep.30875